Facility will provide manufacturing services for inhalation, liquids, topicals and oral solids dosage forms
Pharmaceutical contract development and manufacturing services provider Cirrus Pharmaceuticals, a Kemwell company, has announced that it will invest in a flexible cGMP suite in its facility in Research Triangle Park, NC. The addition of the suite will allow the company to offer cGMP manufacturing services for inhalation, liquids, topicals and oral solids dosage forms. The facility is scheduled to be operational in April 2015.
Kemwell’s R&D division employs 175 scientists worldwide and provides formulation development, analytical development, validation and clinical trial manufacturing.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.